Research Center for Stem Cell Engineering, National Institute of Advanced Industrial Science and Technology, 1-1-1 Higashi, Central 4, Tsukuba, Ibaraki 305-8562, Japan.
J Biol Chem. 2011 Feb 11;286(6):4760-71. doi: 10.1074/jbc.M110.183780. Epub 2010 Dec 7.
The ectopic expression of transcription factors can reprogram differentiated tissue cells into induced pluripotent stem cells. However, this is a slow and inefficient process, depending on the simultaneous delivery of multiple genes encoding essential reprogramming factors and on their sustained expression in target cells. Moreover, once cell reprogramming is accomplished, these exogenous reprogramming factors should be replaced with their endogenous counterparts for establishing autoregulated pluripotency. Complete and designed removal of the exogenous genes from the reprogrammed cells would be an ideal option for satisfying this latter requisite as well as for minimizing the risk of malignant cell transformation. However, no single gene delivery/expression system has ever been equipped with these contradictory characteristics. Here we report the development of a novel replication-defective and persistent Sendai virus (SeVdp) vector based on a noncytopathic variant virus, which fulfills all of these requirements for cell reprogramming. The SeVdp vector could accommodate up to four exogenous genes, deliver them efficiently into various mammalian cells (including primary tissue cells and human hematopoietic stem cells) and express them stably in the cytoplasm at a prefixed balance. Furthermore, interfering with viral transcription/replication using siRNA could erase the genomic RNA of SeVdp vector from the target cells quickly and thoroughly. A SeVdp vector installed with Oct4/Sox2/Klf4/c-Myc could reprogram mouse primary fibroblasts quite efficiently; ∼1% of the cells were reprogrammed to Nanog-positive induced pluripotent stem cells without chromosomal gene integration. Thus, this SeVdp vector has potential as a tool for advanced cell reprogramming and for stem cell research.
转录因子的异位表达可以将分化组织细胞重编程为诱导多能干细胞。然而,这是一个缓慢且低效的过程,取决于同时递呈多个编码必需重编程因子的基因,以及这些基因在靶细胞中的持续表达。此外,一旦细胞重编程完成,就应该用其内源对应物替代这些外源性重编程因子,以建立自我调节的多能性。从重编程细胞中完全且有设计地去除外源性基因是满足这一要求的理想选择,同时也可以最大限度地降低恶性细胞转化的风险。然而,没有任何一种基因传递/表达系统同时具备这些矛盾的特性。在这里,我们报告了一种新型的复制缺陷型和持续性的仙台病毒(SeVdp)载体的开发,该载体基于一种非致细胞病变的变异病毒,它满足了细胞重编程的所有这些要求。SeVdp 载体可以容纳多达四个外源性基因,高效地将它们递呈到各种哺乳动物细胞(包括原代组织细胞和人造血干细胞)中,并在细胞质中以固定的平衡稳定表达。此外,使用 siRNA 干扰病毒转录/复制可以迅速而彻底地从靶细胞中清除 SeVdp 载体的基因组 RNA。一个安装有 Oct4/Sox2/Klf4/c-Myc 的 SeVdp 载体可以相当有效地将小鼠原代成纤维细胞重编程为 Nanog 阳性的诱导多能干细胞,而没有染色体基因整合。因此,这种 SeVdp 载体有可能成为高级细胞重编程和干细胞研究的工具。